default author photo

Mingxin Liu

China Medical University - Cancer Stem Cell and Translation Medicine Lab

SCHOLARLY PAPERS

1

DOWNLOADS

66

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Long-Term Outcomes by Neoadjuvant Efficacy Indexes in Patients with HR and HR /HER2 Breast Cancer after Neoadjuvant Systemic Therapy: A Systematic Review and Meta-Analysis

Number of pages: 22 Posted: 03 Oct 2022
China Medical University - Cancer Stem Cell and Translation Medicine Lab, China Medical University - Cancer Stem Cell and Translation Medicine Lab, China Medical University - Cancer Stem Cell and Translation Medicine Lab, China Medical University - Cancer Stem Cell and Translation Medicine Lab, China Medical University - Cancer Stem Cell and Translation Medicine Lab, China Medical University - Cancer Stem Cell and Translation Medicine Lab, China Medical University - Cancer Stem Cell and Translation Medicine Lab, China Medical University - Cancer Stem Cell and Translation Medicine Lab, China Medical University - Cancer Stem Cell and Translation Medicine Lab, China Medical University - Cancer Stem Cell and Translation Medicine Lab and China Medical University - Cancer Stem Cell and Translation Medicine Lab
Downloads 66 (933,592)

Abstract:

Loading...

breast cancer, hormone receptor positive, human epidermal growth factor receptor 2 positive, neoadjuvant efficacy indexes, prognosis